Combination of rhIL-11+G-CSF enhances platelet (PLT) and myeloid recovery following ifosfamide, carboplatin, and etoposide (ICE) chemotherapy in children with solid tumors (ST): rhIL-11 is well tolerated at double the adult recommended dose
Conferences
Goldman, S; Davenport, V; Reaman, G; Laver, J; Kreissman, S; Blazar, B; Berg, S; Kaye, J; Patterson, F; Cairo, MS
Published in: EXPERIMENTAL HEMATOLOGY
August 1997
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
EXPERIMENTAL HEMATOLOGY
ISSN
0301-472X
Publication Date
August 1997
Volume
25
Issue
8
Start / End Page
201 / 201
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Goldman, S., Davenport, V., Reaman, G., Laver, J., Kreissman, S., Blazar, B., … Cairo, M. S. (1997). Combination of rhIL-11+G-CSF enhances platelet (PLT) and myeloid recovery following ifosfamide, carboplatin, and etoposide (ICE) chemotherapy in children with solid tumors (ST): rhIL-11 is well tolerated at double the adult recommended dose. In EXPERIMENTAL HEMATOLOGY (Vol. 25, pp. 201–201).
Goldman, S., V. Davenport, G. Reaman, J. Laver, S. Kreissman, B. Blazar, S. Berg, J. Kaye, F. Patterson, and M. S. Cairo. “Combination of rhIL-11+G-CSF enhances platelet (PLT) and myeloid recovery following ifosfamide, carboplatin, and etoposide (ICE) chemotherapy in children with solid tumors (ST): rhIL-11 is well tolerated at double the adult recommended dose.” In EXPERIMENTAL HEMATOLOGY, 25:201–201, 1997.
Goldman S, Davenport V, Reaman G, Laver J, Kreissman S, Blazar B, et al. Combination of rhIL-11+G-CSF enhances platelet (PLT) and myeloid recovery following ifosfamide, carboplatin, and etoposide (ICE) chemotherapy in children with solid tumors (ST): rhIL-11 is well tolerated at double the adult recommended dose. In: EXPERIMENTAL HEMATOLOGY. 1997. p. 201–201.
Goldman, S., et al. “Combination of rhIL-11+G-CSF enhances platelet (PLT) and myeloid recovery following ifosfamide, carboplatin, and etoposide (ICE) chemotherapy in children with solid tumors (ST): rhIL-11 is well tolerated at double the adult recommended dose.” EXPERIMENTAL HEMATOLOGY, vol. 25, no. 8, 1997, pp. 201–201.
Goldman S, Davenport V, Reaman G, Laver J, Kreissman S, Blazar B, Berg S, Kaye J, Patterson F, Cairo MS. Combination of rhIL-11+G-CSF enhances platelet (PLT) and myeloid recovery following ifosfamide, carboplatin, and etoposide (ICE) chemotherapy in children with solid tumors (ST): rhIL-11 is well tolerated at double the adult recommended dose. EXPERIMENTAL HEMATOLOGY. 1997. p. 201–201.
Published In
EXPERIMENTAL HEMATOLOGY
ISSN
0301-472X
Publication Date
August 1997
Volume
25
Issue
8
Start / End Page
201 / 201
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology